Long-term potentiation in hippocampus involves sequential activation of soluble guanylate cyclase, cGMP-dependent protein kinase and cGMP-degrading phosphodiesterase, alterations in hyperammonemia.
作者信息
Monfort Pilar, Felipo Vicente
机构信息
Laboratory of Neurobiology, Fundación Valenciana de Investigaciones Biomédicas, Valencia, Spain.
出版信息
BMC Pharmacol. 2005 Jun 16;5 Suppl 1(Suppl 1):P66. doi: 10.1186/1471-2210-5-S1-P66.
Abstract
摘要
相似文献
1
Long-term potentiation in hippocampus involves sequential activation of soluble guanylate cyclase, cGMP-dependent protein kinase and cGMP-degrading phosphodiesterase, alterations in hyperammonemia.海马体中的长时程增强涉及可溶性鸟苷酸环化酶、环磷酸鸟苷依赖性蛋白激酶和环磷酸鸟苷降解磷酸二酯酶的顺序激活，以及高氨血症的改变。
BMC Pharmacol. 2005 Jun 16;5 Suppl 1(Suppl 1):P66. doi: 10.1186/1471-2210-5-S1-P66.
2
Sequential activation of soluble guanylate cyclase, protein kinase G and cGMP-degrading phosphodiesterase is necessary for proper induction of long-term potentiation in CA1 of hippocampus. Alterations in hyperammonemia.可溶性鸟苷酸环化酶、蛋白激酶G和cGMP降解磷酸二酯酶的顺序激活对于海马体CA1区长期增强效应的正确诱导是必要的。高氨血症中的改变。
Neurochem Int. 2004 Nov;45(6):895-901. doi: 10.1016/j.neuint.2004.03.020.
3
Chronic hyperammonemia in vivo impairs long-term potentiation in hippocampus by altering activation of cyclic GMP-dependent-protein kinase and of phosphodiesterase 5.体内慢性高氨血症通过改变环磷酸鸟苷依赖性蛋白激酶和磷酸二酯酶5的活性来损害海马体中的长时程增强效应。
J Neurochem. 2005 Aug;94(4):934-42. doi: 10.1111/j.1471-4159.2005.03236.x.
4
Hyperammonemia impairs long-term potentiation in hippocampus by altering the modulation of cGMP-degrading phosphodiesterase by protein kinase G.高氨血症通过改变蛋白激酶G对环磷酸鸟苷降解磷酸二酯酶的调节作用，损害海马体中的长时程增强效应。
Neurobiol Dis. 2004 Feb;15(1):1-10. doi: 10.1016/j.nbd.2003.09.008.
5
Long-term potentiation in hippocampus involves sequential activation of soluble guanylate cyclase, cGMP-dependent protein kinase, and cGMP-degrading phosphodiesterase.海马体中的长时程增强效应涉及可溶性鸟苷酸环化酶、环磷酸鸟苷依赖性蛋白激酶和环磷酸鸟苷降解磷酸二酯酶的顺序激活。
J Neurosci. 2002 Dec 1;22(23):10116-22. doi: 10.1523/JNEUROSCI.22-23-10116.2002.
6
Molecular mechanisms of the alterations in NMDA receptor-dependent long-term potentiation in hyperammonemia.高氨血症中NMDA受体依赖性长时程增强改变的分子机制
Metab Brain Dis. 2005 Dec;20(4):265-74. doi: 10.1007/s11011-005-7905-5.
7
Cyclic GMP metabolism and its role in brain physiology.环磷酸鸟苷代谢及其在脑生理学中的作用。
J Physiol Pharmacol. 2005 Mar;56 Suppl 2:15-34.
8
Long-term age-dependent behavioral changes following a single episode of fetal N-methyl-D-Aspartate (NMDA) receptor blockade.单次胎儿期N-甲基-D-天冬氨酸（NMDA）受体阻断后长期的年龄依赖性行为变化。
BMC Pharmacol. 2004 Oct 28;4:28. doi: 10.1186/1471-2210-4-28.
9
Increases of guanosine 3',5'-monophosphate-related enzymes in kidneys of developing rats.
Pediatr Res. 1978 Aug;12(8):882-5. doi: 10.1203/00006450-197808000-00017.
10
Impaired effect of salt loading on nitric oxide-mediated relaxation in aortas from stroke-prone spontaneously hypertensive rats.盐负荷对易中风自发性高血压大鼠主动脉中一氧化氮介导的舒张作用的损害。
Clin Exp Pharmacol Physiol. 2007 Jan-Feb;34(1-2):48-54. doi: 10.1111/j.1440-1681.2007.04532.x.
引用本文的文献
1
Influence of the Flavonoid, Quercetin on Antioxidant Status, Lipid Peroxidation and Histopathological Changes in Hyperammonemic Rats.黄酮类化合物槲皮素对高氨血症大鼠抗氧化状态、脂质过氧化及组织病理学变化的影响
Indian J Clin Biochem. 2017 Jul;32(3):275-284. doi: 10.1007/s12291-016-0603-8. Epub 2016 Aug 11.
2
cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action.环鸟苷酸依赖性蛋白激酶和环鸟苷酸磷酸二酯酶在一氧化氮和环鸟苷酸作用中的研究
Pharmacol Rev. 2010 Sep;62(3):525-63. doi: 10.1124/pr.110.002907.
3
Antioxidant Potential of Momordica Charantia in Ammonium Chloride-Induced Hyperammonemic Rats.苦瓜对氯化铵诱导的高氨血症大鼠的抗氧化潜力
Evid Based Complement Alternat Med. 2011;2011:612023. doi: 10.1093/ecam/nep227. Epub 2011 Jun 8.
4
Morin a flavonoid exerts antioxidant potential in chronic hyperammonemic rats: a biochemical and histopathological study.桑色素（一种黄酮类化合物）对慢性高氨血症大鼠具有抗氧化潜力：一项生化与组织病理学研究。
Mol Cell Biochem. 2009 Jul;327(1-2):153-61. doi: 10.1007/s11010-009-0053-1. Epub 2009 Feb 24.
Zotero 插件